(lp0
S'Imprimis Pharma  Says Peer-Reviewed Paper Demonstrates Benefits of ... StreetInsider.com - 16 hours ago Imprimis Pharmaceuticals, Inc. , an ophthalmology-focused pharmaceutical company, today announced the publication of a Dropless Therapy article in the peer-reviewed journal, Current Pharmaceutical Design.'
p1
aS'Imprimis Pharmaceuticals Announces Availability of Lower-Cost Option for the ... PR Newswire  - Oct 17, 2016 SAN DIEGO, Oct. 17, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , a pharmaceutical company focused on the production and dispensing of high quality innovative compounded medications, today announced the availability of a&nbsp;...'
p2
aS'Imprimis Pharmaceuticals Announces Third Quarter 2016 Financial Results PR Newswire  - Nov 14, 2016 14, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , a pharmaceutical company focused on the production and dispensing of high quality innovative compounded medications, today reported financial results for the third quarter 2016.'
p3
aS"Imprimis Pharmaceuticals Announces $9.8 Million Private Placement of Units PR Newswire  - Dec 19, 2016 SAN DIEGO, Dec. 19, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc.  today announced that it has entered into a definitive securities purchase agreement with various accredited investors and certain members of Imprimis' Board of&nbsp;...Imprimis Pharmaceuticals Inc  CEO Mark L Baum Bought $279240 of Shares - GuruFocus.com"
p4
aS'Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2016 ... Yahoo Finance - Mar 7, 2017 SAN DIEGO, March 7, 2017 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , an ophthalmology-focused pharmaceutical company, today reported it will release fourth quarter and fiscal year 2016 financial results after the close of trading on Tuesday,&nbsp;...'
p5
aS'Imprimis Pharmaceuticals Inc. IMMY  Wall Street Journal - Feb 8, 2013 News Imprimis Pharmaceuticals Inc.IMMY. Significant News Only. 03/07/17; Press Release. Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2016 Financial Report Conference Call and Webcast on March 21, 2017 at 4:30 p.m.'
p6
aS"Imprimis Pharmaceuticals' Formulations to be Highlighted at Upcoming Annual ... PR Newswire  - Oct 13, 2016 SAN DIEGO, Oct. 13, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , a pharmaceutical company focused on the production and dispensing of high-quality innovative compounded medications, today announced events featuring its&nbsp;..."
p7
aS'Imprimis Pharmaceuticals Announces Plans to Launch IV Free Conscious ... PR Newswire  - May 5, 2016 SAN DIEGO, May 5, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , a pharmaceutical company focused on the development and commercialization of proprietary and customizable drug formulations, today announced plans to launch&nbsp;...'
p8
aS'Imprimis: A Miracle or Just a Press Release? Wall Street Daily - Oct 23, 2015 Cue howls of outrage, along with threats from politicians that catalyzed a large selloff among pharmaceutical and biotechnology companies.Imprimis Pharmaceuticals to Make Compounded and Customizable Formulation of ... - PR Newswire $750-per-pill AIDS drug now has $1 competition: Pharmaceutical company offers ... - Daily Mail'
p9
aS'Imprimis Pharmaceuticals and FocusScript Partner to Exclusively Offer the ... PR Newswire  - Dec 21, 2016 SAN DIEGO and CREVE COEUR, Mo., Dec. 21, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc.  and Focus Script, LLC, a leading independent specialized pharmacy claims management company, today announced the joint launch of&nbsp;...'
p10
a.